Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06225258

Xanthohumol as an Adjuvant in the Treatment of Septic Shock

Analysis of Anti-inflammatory Effect of Hop Extract Rich in Xanthohumol in Patients Treated for Septic Shock

Sponsor: Medical University of Lublin

Interventions Xanthohumol

Updated 5 times since 2024 Last updated: Jul 1, 2025 Started: Jan 9, 2023 Primary completion: Oct 30, 2025 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates ARDS and Pneumonia and is currently actively recruiting participants. Medical University of Lublin leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Aug 2025 — Present [monthly]

Recruiting PHASE2
Jan 2025 — Aug 2025 [monthly]

Recruiting PHASE2
Sep 2024 — Jan 2025 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Feb 2024 — Jul 2024 [monthly]

Recruiting PHASE2

First recorded

Jan 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Lublin

Data source: Medical University of Lublin

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lublin, Poland